Live Breaking News & Updates on Vaccine Candidate|Page 6

Stay updated with breaking news from Vaccine candidate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Gritstone Bio Inc (GRTS) Reports Q3 2023 Financial Results and Progress in Vaccine Development

Advancements in COVID-19 and Cancer Vaccine Programs Amid Increased R&D Spending ....

Andrew Allen , Clinical Program , National Cancer Institute , Gritstone Bio Inc , Bio Inc , Chief Executive Officer , Cancer Vaccine , Vaccine Candidate , Cash Equivalents , Gritstone Bio , Cash Reserves , Accine Study ,

Pfizer Reports Third-Quarter 2023 Results

Pfizer Reports Third-Quarter 2023 Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Albert Bourla , David Denton , Us Strategic National , Us Centers For Disease , Committee For Medicinal Products Human Use , Pfizer Inc , Advisory Committee On Immunization Practices , European Medicines Agency , Reviral Ltd , Alexion Pharma International Operations , Business Development , European Union , Abbvie Biotechnology Ltd , European Commission , Revenues Drove , Operational Decrease , Diluted Loss Per Share , Significantly Impacted , Non Cash Inventory Write Offs , Which Unfavorably Impacted Reported , Provides All Guidance Components , Revenue Growth Expectation , New Product , Indication Launches , Older Adult , In Line Product Growth Contribute ,

Appili Therapeutics Presents at the 10th International Tularemia Conference

Appili Therapeutics Presents at the 10th International Tularemia Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Carl Gelhaus , Jenna Mcneil , Don Cilla , Us Air Force , Us National Institutes Of Health , Appili Therapeutics Inc , Clinical Research , Triennial International Tularemia Conference , Us Air , International Conferences , Defense Threat Reduction Agency , Tularemia International Society , Company Or Appili , International Tularemia Conference , Funding Commitment , Vaccine Candidate , Non Clinical Research , Live Attenuated Tularemia Vaccine Based , Communications Manager , Appili Therapeutics ,

From Setbacks to Solutions: Pioneering Safe RSV Vaccines for Infants, Children

With respiratory syncytial virus vaccine development for infants and children proceeding slowly, therapeutic developers have focused on passive immunity ....

United States , City Of , United Kingdom , South Lanarkshire , Elizabetha Stillman , Rodericks Tang , Christinel Nelson , Surveillance Research , Vaccine Development For Decades , Nanotechnology In Vaccine Development , Centers For Disease , Protecting Infants , Disease Control , Blue Lake Biotechnology , Blue Lake , Brief History , Enhanced Respiratory Syncytial Virus , Pfizer Announces Positive Top Line Data , Maternal Immunization Trial , Bivalent Respiratory Syncytial Virus , Vaccine Candidate , Nasal Vaccine , Vaccine Development ,

Valneva Reports Positive Initial Phase 3 Safety Data in Adolescents for its Single-Shot Chikungunya Vaccine Candidate

Saint-Herblain (France), August 28, 2023 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today reported positive initial Phase 3 safety data in adolescents for its single-dose chikungunya virus (CHIKV) vaccine candidate VLA1553. Immunogenicity data for the trial are expected in November 2023. Funded by the Coalition for Epidemic Preparedness Innovations (CEPI) and conducted in collaboration with Instituto Butantan, the VLA1553-321 adolescent trial is intended to su ....

United States , Juan Carlos Jaramillo , Joshua Drumm , Instituto Butantan , Drug Administration , Vp Global Communications European Investor Relations , Health Canada , Coalition For Epidemic Preparedness Innovations , European Union Horizon , European Medicines Agency , Euronext Paris , Epidemic Preparedness Innovations , Chief Medical Officer , Biologic License Application , Prescription Drug User Fee Act , Southeast Asia , Middle Income Countries , European Union , Breakthrough Therapy , Priority Review , Chikungunya Virus , Clinical Trial , Safety Profile , European Medicines Agency , Safety Data , Vaccine Candidate ,